EMIT Company
Dr. David Izhaky, CEO of EMIT. EMIT is a new early-stage biotech developing therapeutics to extend healthy lifespan. Our mission is to revolutionize the field of aging by developing innovative therapeutics that reverse and slow the aging process and prevent age-related diseases
Technology:
P4 Medicine
Industry:
Geroscience
Headquarters:
London, England, United Kingdom
Founded Date:
21.06.2018
Employees Number:
1-10
Total Funding:
17000
Estimated Revenue:
$1M to $10M
Last Funding Date:
22.10.2018
Last Funding Type:
Product Crowdfunding
Register and Claim Ownership